METHODS article

Front. Drug Saf. Regul.

Sec. Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Volume 5 - 2025 | doi: 10.3389/fdsfr.2025.1579922

Federated Learning: A Privacy-Preserving Approach to Data-Centric Regulatory Cooperation

Provisionally accepted
Alexander  HorstAlexander Horst1*Paul  LoustalotPaul Loustalot2Sanjeev  YoganathanSanjeev Yoganathan3Ting  LiTing Li4Weida  TongWeida Tong4Joshua  XuJoshua Xu4David  SchneiderDavid Schneider1Erminio  Di RenzoErminio Di Renzo1Nicolas  Perez-LöfflerNicolas Perez-Löffler1Michael  RenaudinMichael Renaudin1
  • 1Swissmedic, Bern, Switzerland
  • 2Quinten Health, Paris, France
  • 3Danish Medicines Agency, Copenhagen, Denmark
  • 4National Center for Toxicological Research (FDA), Jefferson, Arkansas, United States

The final, formatted version of the article will be published soon.

Regulatory agencies aim to ensure the safety and efficacy of medical products but often face legal and privacy concerns that hinder collaboration at the data level. In this paper, we propose federated learning as an innovative method to enhance data-centric collaboration among regulatory agencies by enabling collaborative training of machine learning models without the need for direct data sharing, thereby preserving privacy and overcoming legal hurdles. We illustrate how Swissmedic, the Swiss Agency for Therapeutic Products, together with its partner agencies, proposes to use federated learning to improve TRICIA, an AI tool for assessing incoming reports of serious incidents related to medical devices. This approach enables the development of robust, generalizable risk assessment models that can potentially improve current processes. A proof of concept was deployed and thoroughly tested during the 14th Global Summit on Regulatory Science using synthetic data with participants from Swissmedic, the U.S. Food and Drug Administration (FDA), and the Danish Medicines Agency (DKMA), with promising initial results. This innovation has the potential to serve as a roadmap for other regulators to adopt similar approaches to optimize their own regulatory processes, contributing to a more integrated and efficient regulatory environment worldwide.

Keywords: Federated learning, Regulatory sciences, medical devices, Risk Assessment, Swissmedic

Received: 19 Feb 2025; Accepted: 11 Apr 2025.

Copyright: © 2025 Horst, Loustalot, Yoganathan, Li, Tong, Xu, Schneider, Di Renzo, Perez-Löffler and Renaudin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Alexander Horst, Swissmedic, Bern, Switzerland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more